• Market Capitalisation market-capitalisation-info $1,040 Mln
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning $-129 Mln

Mirum Pharmaceuticals Inc. (MIRM) Share Price

$31.58

As on 06-Dec-2023 16:00 EST

up-down-arrow $-0.92-2.83%

  • Prev Close info

    $32.50

  • Day's Openinfo

    $32.40

  • Today's Highinfo

    $32.83

  • Today's Lowinfo

    $31.56

  • Today's Volumeinfo

    347,280

  • 52 Week rangeinfo

    $17.49 - 33.39

Please wait...

Mirum Pharmaceuticals Inc. (MIRM) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Mirum Pharmaceuticals (MIRM)
61.95 5.27 14.34 72.29 9.58 -- --
S&P BSE Sensex*
14.36 7.11 5.61 11.10 15.57 14.53 12.73
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 06-Dec-2023  |  *As on 07-Dec-2023  |  #As on 26-Oct-2023
2022
2021
2020
Mirum Pharmaceuticals (MIRM)
22.26 -8.65 -28.79
S&P Small-Cap 600
-17.42 25.27 9.57
S&P BSE Sensex
4.44 21.99 15.75

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Mirum Pharmaceuticals Inc. (MIRM) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Mirum Pharmaceuticals Inc. (MIRM)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other details of Mirum Pharmaceuticals Inc. (MIRM)

        Pres, CEO & Director

        Mr. Christopher Peetz

        Chief Financial Officer

        Dr. Ian Clements

        Headquarters

        Foster City, CA

        FAQs for Mirum Pharmaceuticals Inc. (MIRM)

        The total asset value of Mirum Pharmaceuticals Inc. (MIRM) stood at $ 382 Mln as on 31-Mar-23

        The share price of Mirum Pharmaceuticals Inc. (MIRM) is $31.58 (NASDAQ) as of 06-Dec-2023 16:00 EST. Mirum Pharmaceuticals Inc. (MIRM) has given a return of 9.58% in the last 3 years.

        Mirum Pharmaceuticals Inc. (MIRM) has a market capitalisation of $ 1,040 Mln as on 23-Jun-2023. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Mirum Pharmaceuticals Inc. (MIRM) is 3.96 times as on 23-Jun-2023, a 0.56% premium to its peers’ median range of 2.54 times.

        Since, TTM earnings of Mirum Pharmaceuticals Inc. (MIRM) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Mirum Pharmaceuticals Inc. (MIRM) and enter the required number of quantities and click on buy to purchase the shares of Mirum Pharmaceuticals Inc. (MIRM).

        Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

        The CEO & director of Mr. Christopher Peetz. is Mirum Pharmaceuticals Inc. (MIRM), and CFO & Sr. VP is Dr. Ian Clements.

        The promoters of Mirum Pharmaceuticals Inc. (MIRM) have pledged 0% of the total equity as on Mar-23.

        Mirum Pharmaceuticals Inc. (MIRM) Ratios
        Return on equity(%)
        -83.23
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of Mirum Pharmaceuticals Inc. (MIRM) was $-129 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $1,040.17 Mln
        • Revenue (TTM)revenue-information $95.77 Mln
        • Earnings (TTM) earning-information $-129.19 Mln
        • Cash date-information $132.07 Mln
        • Total Debt info $1.97 Mln
        • Insider's Holding 3.78%
        • Liquidity liquidity High
        • 52 Week range week-range $17.49 - 33.39
        • Shares outstanding share-outstanding 38,031,800
        • 5 Years Aggregate:

          CFO: $-381.89 Mln

          EBITDA: $-349.32 Mln

          Net Profit: $-392.82 Mln

        About The Company

        • IPO Date 18-Jul-2019
        • Pres, CEO & Director Mr. Christopher Peetz
        • Chief Financial Officer Dr. Ian Clements
        • Listing key-listing NASDAQ: MIRM
        • Country United States
        • Headquarters headquarters Foster City, CA
        • Website website https://www.mirumpharma.com
        • Business

          Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug...  for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon